ArticleFrontiers in immunology2025

Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension.

Yuyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.